Gyre Therapeutics Ownership | Who Owns Gyre Therapeutics?

Gyre Therapeutics Ownership Summary

Gyre Therapeutics is owned by 3.83% institutional investors, 87.16% insiders, and 9.01% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 0.95% of GYRE shares.

GYRE Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Gyre Therapeutics	3.83%	87.16%	9.01%
Sector	Healthcare Stocks	488.17%	11.08%	-399.26%
Industry	Biotech Stocks	306.59%	11.10%	-217.69%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	842.61K	0.95%	$6.19M
State of wisconsin investment board	37.67K	0.04%	$276.88K
Verition fund management	13.35K	0.01%	$98.09K
American century companies	11.29K	0.01%	$82.99K
Raymond james financial	650.00	0.00%	$4.78K
Activest wealth management	533.00	0.00%	$3.92K
Gamma investing	124.00	0.00%	$911.00
Principal securities	85.00	0.00%	$625.00
Rise advisors	54.00	0.00%	$397.00
Advantage alpha capital partners lp	-	-	-

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Activest wealth management	533.00	0.00%	$3.92K
State of wisconsin investment board	37.67K	0.00%	$276.88K
Verition fund management	13.35K	0.00%	$98.09K
Rise advisors	54.00	0.00%	$397.00
Gamma investing	124.00	0.00%	$911.00
Blackrock funding, inc. /de	842.61K	0.00%	$6.19M
Advantage alpha capital partners lp	-	-	-
Group one trading	-	-	-
Principal securities	85.00	-	$625.00
Corebridge financial	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Blackrock funding, inc. /de	842.61K	0.00%	295.40K
State of wisconsin investment board	37.67K	0.00%	37.67K
Verition fund management	13.35K	0.00%	13.35K
Raymond james financial	650.00	-	650.00
Principal securities	85.00	-	85.00

Top Sellers

Holder	Shares	% Assets	Change
Advantage alpha capital partners lp	-	-	-13.66K
American century companies	11.29K	-	-12.53K
Corebridge financial	-	-	-3.42K
Belvedere trading	-	-	-2.46K
Lazard asset management	-	-	-833.00

New Positions

Holder	Shares	% Assets	Change	Value
State of wisconsin investment board	37.67K	0.00%	37.67K	$276.88K
Verition fund management	13.35K	0.00%	13.35K	$98.09K
Raymond james financial	650.00	-	650.00	$4.78K
Principal securities	85.00	-	85.00	$625.00
Rise advisors	54.00	0.00%	54.00	$397.00

Sold Out

Holder	Change
True wealth design	-6.00
Us bancorp \de\	-17.00
Federation des caisses desjardins du quebec	-75.00
Group one trading	-485.00
Lazard asset management	-833.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	46	4.55%	3,409,780	30.67%	3	41.97%	34	47.83%	7	-50.00%
Mar 31, 2025	44	15.79%	2,609,380	57.10%	3	80.28%	23	15.00%	14	55.56%
Dec 31, 2024	39	11.43%	1,787,607	11.02%	2	59.05%	21	-4.55%	9	50.00%
Sep 30, 2024	35	16.67%	1,610,238	28.03%	1	86.89%	22	-12.00%	6	20.00%
Jun 30, 2024	30	50.00%	1,257,751	53.98%	1	152.85%	25	66.67%	5	25.00%

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 28, 2025	Ma Songjiang	President	Sell	$5.62K
May 27, 2025	Ma Songjiang	President	Sell	$20.56K
May 23, 2025	Ma Songjiang	President	Sell	$1.86K
May 22, 2025	Ma Songjiang	President	Sell	$21.94K
May 20, 2025	Ma Songjiang	President	Sell	$22.50K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	-
2025 Q2	-	12
2025 Q1	-	59
2024 Q4	-	14
2024 Q3	-	-

GYRE Ownership FAQ

Who Owns Gyre Therapeutics?

Gyre Therapeutics shareholders are primarily institutional investors at 3.83%, followed by 87.16% insiders and 9.01% retail investors. The average institutional ownership in Gyre Therapeutics's industry, Biotech Stocks , is 306.59%, which Gyre Therapeutics falls below.

Who owns the most shares of Gyre Therapeutics?

Gyre Therapeutics’s largest shareholders are Blackrock funding, inc. /de (842.61K shares, 0.95%), State of wisconsin investment board (37.67K shares, 0.04%), and Verition fund management (13.34K shares, 0.01%). Together, they hold 1.00% of Gyre Therapeutics’s total shares outstanding.

Does Blackrock own Gyre Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Gyre Therapeutics.

Who is Gyre Therapeutics’s biggest shareholder by percentage of total assets invested?

Activest wealth management is Gyre Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 533 Gyre Therapeutics shares, valued at 3.92K$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools